Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications emergence new paradigm understanding cardiovascular system pulse synchronized
… to quantitatively assess the benefit/risk tradeoff of your new treatment regimen. Healthcare Resource Utilization Our … to demonstrate the cost and healthcare benefits of your new treatment. Exploratory Data Analysis In addition to …
… Childhood Immunization Share on: September 9, 2022 New Research on the Public Health and Economic Benefits of … and the economic impact of this disease prevention. These new studies were conducted because of changes in disease …
Webinar: Characteristics of Recent PRO Labeling by the FDA and EMA for Oncology Drugs Share on: Wednesday, March 13 - Thursday, March 14, 2019 Watch the Recording Trends in EMA and FDA Labeling Based on Patient-Reported Outcomes (PROs) A recent review of …
… Response time and attention Respondents’ self-reported understanding of the survey Failure rate of an internal …
… data elements, we can help you identify and incorporate new research – whether that is conducting prospective or retrospective studies or via new analytics. Beyond that, we can create reports for regulatory and HTA purposes as well as publications, interactive tools, and models to help you …
… safety study sponsored by AstraZeneca, we evaluated cardiovascular safety endpoints related to the use of … stroke, and other major adverse cardiac events in new users of aclidinium, aclidinium/formoterol, and other inhaled COPD medications compared with new users of long-acting beta agonists. This cohort study …
… studies in nutritional epidemiology following the paradigm of a target trial. Xabier Garcia de Albéniz, …
… of results Support for scientific presentations and publications And each step will be delivered with the rigor …
… disorder (MDD) is a leading cause of disability worldwide. Understanding the impact of MDD on quality of life has become … MDD patients receiving pharmacological intervention. For new MDD therapies to gain reimbursement approval, … cost-utility analyses that help to understand whether new treatments are cost-effective. Utility values are …
… with spontaneous reports of serious bleeding and cardiovascular effects, including heart attacks, anginas, and … to evaluate the effectiveness of such measures on new users of cilostazol in Europe. The study was conducted in … of smoking before initiation decreased only in Spain. Cardiovascular contraindications decreased in all study …